ʻO ka weheweheʻana
Uaʻikeʻia nō hoʻi kā mākou Thoucitinib ma waena o Cis-1-Benzyl-4-ʻo Materyll-3-Materylaminopiperidice a he helu helu 1062580-2. ʻO ka waena waena he kī nui i ka hanaʻana o ka torfacitinib, he lāʻau lapaʻau i hoʻohanaʻia e mālama ai i ka lāʻau bheomatoid. As theyy intermediates in the synthesis of tloacitinib, he nui nā huahana i nā mea noiʻi lāʻau lapaʻau a me nā mea hana.
ʻO kēia hui pūʻana o ka waena waena e hoʻopili pono ana e hōʻoia i ke kiʻekiʻe kiʻekiʻe o ka maʻemaʻe a me ka hoʻomau. Me kā mākou mau hana hana hana-ʻo-ka-kiʻi a me nā mea hoʻokele waiwai koʻikoʻi, hiki iāʻoe ke hilinaʻi i ko mākou mauʻoihana hoʻokūkū kiʻekiʻe loa no ka maʻemaʻe a me ka paʻa.
ʻO Torcititinib i waena (3R, 4r) -1-benzyl-3- (MMITHYLPIPILDILIDE ma nā noi waiwai a me ka noiʻiʻana i nā mea noiʻi. Inā paha e hana ana i ka noiʻi haʻawina a iʻole ka hoʻomohalaʻana i nā lāʻau lapaʻau, e hāʻawi i kā mākou mau kikowaena waena a me nā hopena kūpono i kāu mau pono kūpono.
Koho iā mākou
ʻO Jdk i nā hale hana mua o nā papa mua a me nā mea hoʻokele waiwai kūpono, e hōʻoia ana i ka nui o ka pono o ka API i kauʻia. ʻO ka hui loea e hoʻopiʻi iā R & D o ka huahana. E kū'ē iā lāua, keʻimi nei mākou no CMM & CDMO ma ka hale kūʻai home a me ka mākeke honua.